Correlation Between Inhibrx and Mink Therapeutics

Can any of the company-specific risk be diversified away by investing in both Inhibrx and Mink Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Mink Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Inhibrx and Mink Therapeutics, you can compare the effects of market volatilities on Inhibrx and Mink Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Mink Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Mink Therapeutics.

Diversification Opportunities for Inhibrx and Mink Therapeutics

-0.57

Correlation Coefficient

Inhibrx  Mink Therapeutics

Excellent diversification

The 3 months correlation between Inhibrx and Mink is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Mink Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mink Therapeutics and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Mink Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mink Therapeutics has no effect on the direction of Inhibrx i.e., Inhibrx and Mink Therapeutics go up and down completely randomly.

Pair Corralation between Inhibrx and Mink Therapeutics

Given the investment horizon of 90 days Inhibrx is expected to generate 0.76 times more return on investment than Mink Therapeutics. However, Inhibrx is 1.32 times less risky than Mink Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Mink Therapeutics is currently generating about -0.01 per unit of risk. If you would invest  3,218  in Inhibrx on July 21, 2024 and sell it today you would lose (1,618) from holding Inhibrx or give up 50.28% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Inhibrx  vs.  Mink Therapeutics

Inhibrx

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Inhibrx are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental drivers, Inhibrx showed solid returns over the last few months and may actually be approaching a breakup point.

Mink Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mink Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward-looking signals remain comparatively stable which may send shares a bit higher in November 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Inhibrx and Mink Therapeutics

The main advantage of trading using opposite Inhibrx and Mink Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Mink Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mink Therapeutics will offset losses from the drop in Mink Therapeutics' long position.

The idea behind Inhibrx and Mink Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.